Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM355 in R/R B-NHL
NCT05210868Phase 2Active, not recruiting
- Sponsor
- InnoCare Pharma
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Modality
- Bispecific Antibodies, T-cell Engagers, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CM355 in B-cell non-Hodgkin lymphoma, sponsored by InnoCare Pharma. Started Nov 2021; status: active, not recruiting.
02
Drugs
CM355
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05210868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05210868.